Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
CYP21A2 deficiency represents 95% of congenital adrenal hyperplasia (CAH) cases, a group of genetic disorders that affect steroid biosynthesis. The genetic and functional analysis provide critical tools to elucidate complex CAH cases. One of the most accessible tools to infer the pathogenicity of ne...
Saved in:
Main Authors: | Mayara J. Prado (Author), Rodrigo Ligabue-Braun (Author), Arnaldo Zaha (Author), Maria Lucia Rosa Rossetti (Author), Amit V. Pandey (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation☆☆
by: Cristiane Kopacek, et al.
Published: (2019) -
Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation
by: Cristiane Kopacek, et al.
Published: (2019) -
Co-existence of Congenital Adrenal Hyperplasia and Familial Hypokalemic Periodic Paralysis due to CYP21A2 and SCN4A Pathogenic Variants
by: Tuğba Kontbay, et al.
Published: (2021) -
Implications of CYP21A2 gene duplications in carrier screening and prenatal diagnosis of congenital adrenal hyperplasia due to 21 Hydroxylase deficiency
by: Sudhisha Dubey, et al.
Published: (2022) -
Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency through molecular genetic analysis of the CYP21A2 gene
by: Ji-Hee Yoon, et al.
Published: (2024)